<div><p>Changes in BSR threshold (<b>A</b>) and maximum operant response rate (MAX, <b>B</b>) 46-60 minutes after i.p. aripiprazole injections are shown. Values are expressed as mean percentages of pre-injection baselines ± SEM. </p> <p>Asterisks (*) indicate <i>p</i> < 0.05 vs. vehicle (V). <b>C</b>. Mean distance traveled (± SEM) before and after injection of vehicle (VEH) or aripiprazole (ARI, 0.1 mg/kg i.p.) in 15-minute intervals. Shading indicates post-injection time points. <b>D</b>. Mean change in locomotion (± SEM) as a percentage of pre-injection baseline activity for 60 minutes after injection of vehicle (VEH) or aripiprazole (ARI, 0.1 mg/kg i.p.).</p></div
Aripiprazole is an atypical antipsychotic that acts as a partial agonist at the dopamine D-2 recepto...
<p>(A) Effect of S 47445 (10, 30 and 100 mg/kg, p.o.) on spontaneous locomotor activity recorded for...
<p>Ten days following the 5 day sensitization paradigm (see <a href="http://www.plosone.org/article/...
[[abstract]]Dopamine receptor partial agonists have been proposed as potential candidate agents to t...
<div><p>Changes in BSR threshold (<b>A</b>) and maximum operant response rate (MAX, <b>B</b>) 31-45 ...
<p>Changes in BSR threshold (<b>A</b>) and maximum operant response rate (MAX, <b>B</b>) 31-45 minut...
ABSTR ACT: Aripiprazole is a third-generation atypical antipsychotic and a dopamine D2 receptor part...
<p>Changes in BSR threshold (<b>A</b>) and maximum operant response rate (MAX, <b>B</b>) in the firs...
<p>(A) The locomotor activity after various doses of MPH. Each mouse was placed in a locomotor activ...
Aripiprazole is an atypical antipsychotic drug primarily characterized by partial agonist activity a...
<p>Baseline activities were monitored over 30 min, the mice were injected (i.p.) with vehicle, or 30...
<p>(<b>A</b>) Illustration depicting the behavior paradigm used to assess spontaneous locomotor acti...
The present study investigated how repeated administration of aripiprazole (a novel antipsychotic dr...
<p>(a) Locomotor activity during the 30 min habituation session. Data are expressed as the mean dist...
<p>Each day for 5 consecutive days, <i>Dbh +/−</i> mice were administered saline (n = 9), disulfiram...
Aripiprazole is an atypical antipsychotic that acts as a partial agonist at the dopamine D-2 recepto...
<p>(A) Effect of S 47445 (10, 30 and 100 mg/kg, p.o.) on spontaneous locomotor activity recorded for...
<p>Ten days following the 5 day sensitization paradigm (see <a href="http://www.plosone.org/article/...
[[abstract]]Dopamine receptor partial agonists have been proposed as potential candidate agents to t...
<div><p>Changes in BSR threshold (<b>A</b>) and maximum operant response rate (MAX, <b>B</b>) 31-45 ...
<p>Changes in BSR threshold (<b>A</b>) and maximum operant response rate (MAX, <b>B</b>) 31-45 minut...
ABSTR ACT: Aripiprazole is a third-generation atypical antipsychotic and a dopamine D2 receptor part...
<p>Changes in BSR threshold (<b>A</b>) and maximum operant response rate (MAX, <b>B</b>) in the firs...
<p>(A) The locomotor activity after various doses of MPH. Each mouse was placed in a locomotor activ...
Aripiprazole is an atypical antipsychotic drug primarily characterized by partial agonist activity a...
<p>Baseline activities were monitored over 30 min, the mice were injected (i.p.) with vehicle, or 30...
<p>(<b>A</b>) Illustration depicting the behavior paradigm used to assess spontaneous locomotor acti...
The present study investigated how repeated administration of aripiprazole (a novel antipsychotic dr...
<p>(a) Locomotor activity during the 30 min habituation session. Data are expressed as the mean dist...
<p>Each day for 5 consecutive days, <i>Dbh +/−</i> mice were administered saline (n = 9), disulfiram...
Aripiprazole is an atypical antipsychotic that acts as a partial agonist at the dopamine D-2 recepto...
<p>(A) Effect of S 47445 (10, 30 and 100 mg/kg, p.o.) on spontaneous locomotor activity recorded for...
<p>Ten days following the 5 day sensitization paradigm (see <a href="http://www.plosone.org/article/...